These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37032818)

  • 1. Prefrontal EEG slowing, synchronization, and ERP peak latency in association with predementia stages of Alzheimer's disease.
    Choi J; Ku B; Doan DNT; Park J; Cha W; Kim JU; Lee KH
    Front Aging Neurosci; 2023; 15():1131857. PubMed ID: 37032818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal event-related potential markers in association with mild cognitive impairment.
    Eyamu J; Kim WS; Kim K; Lee KH; Kim JU
    Front Aging Neurosci; 2023; 15():1273008. PubMed ID: 37927335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal intra-individual ERP variability and its asymmetry: exploring its biomarker potential in mild cognitive impairment.
    Eyamu J; Kim WS; Kim K; Lee KH; Kim JU
    Alzheimers Res Ther; 2024 Apr; 16(1):83. PubMed ID: 38615028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks.
    Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA
    Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 6. Longitudinal resting-state EEG in amyloid-positive patients along the Alzheimer's disease continuum: considerations for clinical trials.
    Scheijbeler EP; de Haan W; Stam CJ; Twisk JWR; Gouw AA
    Alzheimers Res Ther; 2023 Oct; 15(1):182. PubMed ID: 37858173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cross-frequency coupling analysis of resting-state EEG in patients with mild cognitive impairment and Alzheimer's disease.
    Chen X; Li Y; Li R; Yuan X; Liu M; Zhang W; Li Y
    Front Aging Neurosci; 2023; 15():1142085. PubMed ID: 37600515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
    PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study.
    Ferreri F; Guerra A; Vollero L; Ponzo D; Määtta S; Könönen M; Vecchio F; Pasqualetti P; Miraglia F; Simonelli I; Corbetta M; Rossini PM
    Front Aging Neurosci; 2021; 13():737281. PubMed ID: 34880743
    [No Abstract]   [Full Text] [Related]  

  • 10. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
    Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T
    Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.
    Smailovic U; Kåreholt I; Koenig T; Ashton NJ; Winblad B; Höglund K; Nilsson P; Zetterberg H; Blennow K; Jelic V
    J Alzheimers Dis; 2021; 83(1):355-366. PubMed ID: 34334389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer's dementia.
    Azami H; Zrenner C; Brooks H; Zomorrodi R; Blumberger DM; Fischer CE; Flint A; Herrmann N; Kumar S; Lanctôt K; Mah L; Mulsant BH; Pollock BG; Rajji TK;
    Alzheimers Res Ther; 2023 Aug; 15(1):133. PubMed ID: 37550778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A holo-spectral EEG analysis provides an early detection of cognitive decline and predicts the progression to Alzheimer's disease.
    Chu KT; Lei WC; Wu MH; Fuh JL; Wang SJ; French IT; Chang WS; Chang CF; Huang NE; Liang WK; Juan CH
    Front Aging Neurosci; 2023; 15():1195424. PubMed ID: 37674782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive MMN and P300 in mild cognitive impairment and Alzheimer's disease: A high density EEG-3D vector field tomography approach.
    Papadaniil CD; Kosmidou VE; Tsolaki A; Tsolaki M; Kompatsiaris IY; Hadjileontiadis LJ
    Brain Res; 2016 Oct; 1648(Pt A):425-433. PubMed ID: 27485659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Dementia With Prefrontal Electroencephalography and Event-Related Potential.
    Doan DNT; Ku B; Choi J; Oh M; Kim K; Cha W; Kim JU
    Front Aging Neurosci; 2021; 13():659817. PubMed ID: 33927610
    [No Abstract]   [Full Text] [Related]  

  • 16. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer's disease using EEG technology.
    Jiao B; Li R; Zhou H; Qing K; Liu H; Pan H; Lei Y; Fu W; Wang X; Xiao X; Liu X; Yang Q; Liao X; Zhou Y; Fang L; Dong Y; Yang Y; Jiang H; Huang S; Shen L
    Alzheimers Res Ther; 2023 Feb; 15(1):32. PubMed ID: 36765411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulus-induced gamma rhythms are weaker in human elderly with mild cognitive impairment and Alzheimer's disease.
    Murty DV; Manikandan K; Kumar WS; Ramesh RG; Purokayastha S; Nagendra B; Ml A; Balakrishnan A; Javali M; Rao NP; Ray S
    Elife; 2021 Jun; 10():. PubMed ID: 34099103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Subjective Cognitive Decline Recognition and the Potential of Molecular and Neurophysiological Biomarkers-A Systematic Review.
    Ulbl J; Rakusa M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.